325 related articles for article (PubMed ID: 19596526)
1. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP
Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
3. Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.
van Dekken H; Verhoef C; Wink J; van Marion R; Vissers KJ; Hop WC; de Man RA; IJzermans JN; van Eijck CH; Zondervan PE
Acta Histochem; 2005; 107(3):161-71. PubMed ID: 16000213
[TBL] [Abstract][Full Text] [Related]
4. Subtype classification of hepatocellular adenoma.
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Dig Surg; 2010; 27(1):39-45. PubMed ID: 20357450
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
6. Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma.
Yang MD; Wu CC; Chiou SH; Chiu CF; Lin TY; Chiang IP; Chow KC
Oncol Rep; 2003; 10(2):271-6. PubMed ID: 12579257
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease.
Kishnani PS; Chuang TP; Bali D; Koeberl D; Austin S; Weinstein DA; Murphy E; Chen YT; Boyette K; Liu CH; Chen YT; Li LH
Hum Mol Genet; 2009 Dec; 18(24):4781-90. PubMed ID: 19762333
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects.
Hata S; Miki Y; Fujishima F; Sato R; Okaue A; Abe K; Ishida K; Akahira J; Unno M; Sasano H
Life Sci; 2010 Mar; 86(11-12):393-401. PubMed ID: 20102722
[TBL] [Abstract][Full Text] [Related]
9. Involvement of RhoA in progression of human hepatocellular carcinoma.
Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase expression in hepatitis B virus-associated human hepatocellular carcinogenesis.
Zhou T; Evans AA; London WT; Xia X; Zou H; Shen F; Clapper ML
Cancer Res; 1997 Jul; 57(13):2749-53. PubMed ID: 9205086
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome p450 and glutathione transferase expression in squamous cell cancer.
Ali S; El-Rayes BF; Heilbrun LK; Sarkar FH; Ensley JF; Kucuk O; Philip PA
Clin Cancer Res; 2004 Jul; 10(13):4412-6. PubMed ID: 15240530
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta 1 in human liver tumors.
Vogelbruch M; Wellmann A; Maschek H; Schäfer MK; Flemming P; Georgii A
Verh Dtsch Ges Pathol; 1995; 79():132-6. PubMed ID: 8600677
[TBL] [Abstract][Full Text] [Related]
13. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954
[TBL] [Abstract][Full Text] [Related]
14. [The mutation of deletion for glutathione S-transferase M1 gene in the tissue of hepatocellular carcinoma].
Bian J; Shen F; Wang J; Chen G; Zhang B; Wu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Jun; 16(3):171-3. PubMed ID: 10359869
[TBL] [Abstract][Full Text] [Related]
15. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma: susceptibility markers.
Blum HE
IARC Sci Publ; 2001; 154():241-4. PubMed ID: 11220663
[TBL] [Abstract][Full Text] [Related]
17. Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas.
Haas S; Pierl C; Harth V; Pesch B; Rabstein S; Brüning T; Ko Y; Hamann U; Justenhoven C; Brauch H; Fischer HP
Int J Cancer; 2006 Oct; 119(8):1785-91. PubMed ID: 16721811
[TBL] [Abstract][Full Text] [Related]
18. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM
Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
20. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]